# Catherine Dubos Arvis

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/catherine-dubos-arvis/

## Facts

| Field | Value |
| --- | --- |
| Citations | 8,425 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 13 |
| i10-index | 14 |
| Last Known Institution | Centre François Baclesse |
| OpenAlex ID | https://openalex.org/A5050112931 |
| Works | 23 |

## Researcher papers

- [Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial](https://scholariq.org/papers/pembrolizumab-versus-docetaxel-for-previously-treated-pd-l1-positive-advanced/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)

## Researcher university

- [Centre François Baclesse](https://scholariq.org/institutions/centre-francois-baclesse-2/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.